You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
Intersection of immune and oncometabolic pathways drives cancer hyperprogression during immunotherapy
|
|---|---|
| Published in |
Cancer Cell, January 2023
|
| DOI | 10.1016/j.ccell.2022.12.008 |
| Pubmed ID | |
| Authors |
Gaopeng Li, Jae Eun Choi, Ilona Kryczek, Yilun Sun, Peng Liao, Shasha Li, Shuang Wei, Sara Grove, Linda Vatan, Reagan Nelson, Grace Schaefer, Steven G Allen, Kamya Sankar, Leslie A Fecher, Mishal Mendiratta-Lala, Timothy L Frankel, Angel Qin, Jessica J Waninger, Alangoya Tezel, Ajjai Alva, Christopher D Lao, Nithya Ramnath, Marcin Cieslik, Paul W Harms, Michael D Green, Arul M Chinnaiyan, Weiping Zou |
X Demographics
The data shown below were collected from the profiles of 223 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 59 | 26% |
| Spain | 11 | 5% |
| France | 10 | 4% |
| Italy | 10 | 4% |
| Brazil | 6 | 3% |
| United Kingdom | 5 | 2% |
| India | 5 | 2% |
| Mexico | 4 | 2% |
| Colombia | 3 | 1% |
| Other | 30 | 13% |
| Unknown | 80 | 36% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 124 | 56% |
| Scientists | 60 | 27% |
| Practitioners (doctors, other healthcare professionals) | 30 | 13% |
| Science communicators (journalists, bloggers, editors) | 9 | 4% |
Mendeley readers
The data shown below were compiled from readership statistics for 89 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 89 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 24 | 27% |
| Student > Ph. D. Student | 14 | 16% |
| Student > Master | 8 | 9% |
| Student > Bachelor | 5 | 6% |
| Unspecified | 3 | 3% |
| Other | 7 | 8% |
| Unknown | 28 | 31% |
| Readers by discipline | Count | As % |
|---|---|---|
| Biochemistry, Genetics and Molecular Biology | 23 | 26% |
| Immunology and Microbiology | 14 | 16% |
| Medicine and Dentistry | 9 | 10% |
| Agricultural and Biological Sciences | 6 | 7% |
| Pharmacology, Toxicology and Pharmaceutical Science | 3 | 3% |
| Other | 6 | 7% |
| Unknown | 28 | 31% |
Attention Score in Context
This research output has an Altmetric Attention Score of 218. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 17 March 2024.
All research outputs
#180,930
of 25,775,807 outputs
Outputs from Cancer Cell
#70
of 3,182 outputs
Outputs of similar age
#4,816
of 480,216 outputs
Outputs of similar age from Cancer Cell
#2
of 36 outputs
Altmetric has tracked 25,775,807 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 3,182 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 37.4. This one has done particularly well, scoring higher than 97% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 480,216 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 99% of its contemporaries.
We're also able to compare this research output to 36 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 94% of its contemporaries.